Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DX25F6XTL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $65,000
Award facts
- Contract value 100% obligated
- $64,999.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $65K on September 16, 2025, for the supply of Stelara 90 mg/mL syringes. The order is set to be completed by October 7, 2025, and will be fulfilled from the company's Park Ridge location. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, a $500M vehicle that enables the procurement of pharmaceutical products and medical supplies to support Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in government procurement without set-aside restrictions. The company maintains a robust portfolio of federal contracts covering an extensive range of medications and biologics, from specialty oncology treatments to vaccines and auto-injectors. Stelara, a biologic immunosuppressant, supports the medical supply needs of military healthcare systems, demonstrating the vendor's role in providing essential pharmaceutical products to Department of Defense facilities across the nation.
Quick answers
Who was awarded contract SPE2DX25F6XTL?
SPE2DX25F6XTL was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 16, 2025.
How much is contract SPE2DX25F6XTL worth?
The government has obligated $65,000 on SPE2DX25F6XTL.
Is contract SPE2DX25F6XTL an order under another contract?
Yes. SPE2DX25F6XTL is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XTL competed?
The extent of competition for SPE2DX25F6XTL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award